INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2156955004-white-gloves-with-eye-drops-medicine]( "Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection")
Overcoming Challenges In Ophthalmic Formulations Through Polymer SelectionThe growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.
-
![Assessing Particle Generation In A Single-Use Mixing System]( "Assessing Particle Generation In A Single-Use Mixing System")
Assessing Particle Generation In A Single-Use Mixing SystemExplore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
![GettyImages-2174865889-scientists-laboratory-equipment-analysis]( "Quantification Of Semaglutide With A Reliable Analytical Method")
Quantification Of Semaglutide With A Reliable Analytical MethodExplore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.
-
![2025 Trends Blog Cover Image]( "5 Trends Impacting CMOs In 2025")
5 Trends Impacting CMOs In 2025In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
How Recent Trends Impact Bringing Your Molecule To Market7/9/2024
With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.
-
Developing A Quantitative Surrogate Peptide Assay7/17/2025
Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.
-
Driving Efficiency Through Process Intensification10/3/2025
Discover how intensification strategies reduce costs and waste while boosting throughput, sustainability, and operational value, which offers a smarter, more scalable approach to manufacturing.
-
Accelerating Development With Rapid Delivery Of Toxicological Study Material3/19/2025
Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.
-
Biologic Stability: A Thermofluor Screen For Rational Buffer Optimization9/23/2025
Learn how thermal shift fluorimetry (thermofluor) can be used as a rapid, low-volume, and cost-effective technique to accelerate buffer optimization and enhance protein stability.
DRUG DEVELOPMENT SOLUTIONS
-
![Asahi Kasei - 450x300_IBF]( "The Buyer's Guide To Buffer Formulation Equipment")
Purchasing buffer formulation equipment involves more than just price. Explore critical features, budget considerations, and vendor qualifications to secure a reliable system that meets your needs.
-
![Scientist standing with SpectraMax iD5e mutlt-mode microplate reader gas mixer included]( "SpectraMax iD3s And iD5e Multi-Mode Microplate Readers")
Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.
The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.
-
![Microscope pipette GettyImages-503258063]( "Speed, Scale, And Supply With Innovative Cell Culture Solutions")
Our comprehensive network of manufacturing facilities enables us to offer robust supply assurance and consistent product quality to biopharmaceutical developers around the globe.
-
![adarapharma2]( "Adare Pharma Solutions (APS) Orbis Overview")
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
![GettyImages-1268717577-doctor-meeting-with-business-professional-computer-office]( "Accelerating FIH Trials To POC With Speed, Safety, And Certainty")
Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.
